Green Oleo Valuation

Q: What is the Fair Price of 77M when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

77M (€0.88) is trading above our estimate of [[fair value]] (€0.84)

Is 77M undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 77M when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 77M (€0.88) is trading above our estimate of fair value (€0.84)

Significantly Below Fair Value: 77M is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 77M?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 77M. This is calculated by dividing 77M's market cap by their current preferred multiple.
What is 77M's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	€28.42m

77M key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.6x
Enterprise Value/EBITDA	16.9x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 77M's PS Ratio compare to its peers?

The above table shows the PS ratio for 77M vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.7x
IBU IBU-tec advanced materials	0.9x	22.5%	€44.7m
SIM0 SIMONA	0.7x	n/a	€393.0m
NSAK OTI Greentech	0.04x	n/a	€633.3k
BNN BRAIN Biotech	1x	9.9%	€58.6m
77M Green Oleo	0.4x	8.9%	€28.4m

Price-To-Sales vs Peers: 77M is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (0.7x).

Price to Earnings Ratio vs Industry

How does 77M's PE Ratio compare vs other companies in the DE Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	38.9%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	38.9%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: 77M is good value based on its Price-To-Sales Ratio (0.4x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is 77M's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

77M PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.4x
Fair PS Ratio	0.1x

Price-To-Sales vs Fair Ratio: 77M is expensive based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 77M forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	€0.88	€1.75 +98.9%	8.6%	€1.90	€1.60	n/a	2
Sep ’25	€0.96	€1.75 +82.3%	8.6%	€1.90	€1.60	n/a	2
Aug ’25	€0.90	€1.75 +94.4%	8.6%	€1.90	€1.60	n/a	2
Jul ’25	€0.92	€1.75 +90.2%	8.6%	€1.90	€1.60	n/a	2
Jun ’25	€0.91	€1.75 +93.4%	8.6%	€1.90	€1.60	n/a	2
May ’25	€0.89	€1.75 +96.6%	8.6%	€1.90	€1.60	n/a	2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.